| Study on the Influence of Climatic and Environmental Factors on Respiratory Diseases in Sanya, Hainan Province, China. (NCT05330637) | Shanghai Jiao Tong University School of Medicine | 2022-03-03 |
| Sinolpan® Pharmacy Non-interventional Study - Quality of Live (NCT04703673) | Engelhard Arzneimittel GmbH & Co.KG | 2021-01-08 |
| Energy Supply in Athletes and Untrained Persons With Bronchopulmonary Diseases (NCT04415827) | I.M. Sechenov First Moscow State Medical University | 2020-05-23 |
| Clinical Validation of Omron WheezeScan (NCT04144699) | Omron Healthcare Co., Ltd. | 2019-11-01 |
| Multiple Breath Washout, a Clinimetric Dataset (NCT03320382) | Imperial College London | 2017-05-05 |
| A Safety Study of Balsamic Bactrim in Pediatric Participants With Acute Bronchitis (NCT02879981) | Hoffmann-La Roche | 2016-11-10 |
| An Add-on Study to Evaluate the Efficacy and Safety of Xiyanping Injection in Pediatric Bronchitis Patients. (NCT02937857) | Jiangxi Qingfeng Pharmaceutical Co. Ltd. | 2016-08-01 |
| Crossover, Single Dose, Two-stage Bioequivalence Study of SCMC-Lys Salt 1.35 g Powder vs SCMC-Lys Salt 90 mg/mL Syrup (NCT02858193) | Dompé Farmaceutici S.p.A | 2016-07-04 |
| A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients (NCT02087761) | Luminex Corporation | 2015-12-01 |
| Treatment of Respiratory Tract Infection and/or Acute Bronchitis With Ectoin Inhalation Solution (NCT02632851) | Bitop AG | 2015-12-01 |
| Therapy of Ventilator-associated Tracheobronchitis Caused by Gram Negative Bacteria With Nebulized Colistin (NCT02619786) | Mahidol University | 2015-12-01 |
| A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel (NCT01787227) | Luminex Molecular Diagnostics | 2015-01-01 |
| A Registry Study on Tanreqing（a Chinese Medicine Injection）Used in Hospitals in China (NCT01824732) | China Academy of Chinese Medical Sciences | 2013-01-01 |
| Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis (NCT02913365) | Université de Sherbrooke | 2012-10-01 |
| Mepolizumab in Chronic Obstructive Pulmonary Diseases (COPD) With Eosinophilic Bronchitis (NCT01463644) | McMaster University | 2012-01-01 |
| A Registry Study on Xiyanping(a Chinese Medicine Injection) Used in Fifty Hospitals (NCT01612572) | China Academy of Chinese Medical Sciences | 2012-01-01 |
| CRP-guided Antibiotic Treatment in COPD Exacerbations Admitted to the Hospital (NCT01232140) | Medical Center Alkmaar | 2011-07-01 |
| Outcome Study to Evaluate Klaricid XL® (Clarithromycin Modified Release) in Patients With Acute Exacerbation of Chronic Bronchitis (NCT01354938) | Abbott | 2011-05-01 |
| Demonstration of Near Zero Antibiotic Prescribing for Acute Bronchitis (NCT01240174) | Brigham and Women's Hospital | 2011-03-01 |
| Prognostic Indicators as Provided by the EPIC ClearView (NCT01476995) | Epic Research & Diagnostics, Inc. | 2010-09-01 |
| Evaluation of the Treatment With Klacid®SR in Patients With Lower Respiratory Tract Infection (NCT01108185) | Abbott | 2010-03-01 |
| Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of "AG NPP709 Syrup" (NCT01151202) | Ahn-Gook Pharmaceuticals Co.,Ltd | 2010-02-01 |
| Evaluation of Effectiveness of the Treatment After Repeated Administration of Klacid®SR (NCT01130883) | Abbott | 2010-02-01 |
| Prophylactic Efficacy of Relenza Against Influenza A and B (NCT01156701) | GlaxoSmithKline | 2009-07-01 |
| Functional Implications of TNF (NCT00729131) | National Institute of Environmental Health Sciences (NIEHS) | 2008-08-01 |
| Phase 4 Study - Mucinex D as Adjunct Therapy (NCT00441246) | Adams Respiratory Therapeutics | 2007-02-01 |
| Efficacy Safety Study of Arformoterol/Tiotropium Combination Versus Either Therapy Alone in Chronic Obstructive Pulmonary Disease (COPD) (NCT00424528) | Sumitomo Pharma America, Inc. | 2006-12-01 |
| Effect of the Consumption of a Fermented Milk on Common Infections in Adults Submitted to Multi-stressor Situation (NCT01315418) | Danone Global Research & Innovation Center | 2006-12-01 |
| Effect of the Consumption of a Fermented Milk on Common Infections in Shift-workers (NCT01033799) | Danone Global Research & Innovation Center | 2006-10-01 |
| Procalcitonin Guided Antibiotic Therapy and Hospitalisation in Patients With Lower Respiratory Tract Infections: The "ProHOSP" Study (NCT00350987) | University Hospital, Basel, Switzerland | 2006-10-01 |
| Procalcitonin as a Marker of Bacterial Pneumonia (NCT00415753) | Aarhus University Hospital Skejby | 2006-06-01 |
| Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease (NCT00250679) | Sumitomo Pharma America, Inc. | 2005-10-01 |
| Evaluation of the Lungs of Individuals With Lung Disease (NCT00224198) | Weill Medical College of Cornell University | 2004-01-01 |
| Effect of Ipratropium on Acute Bronchitis in Subjects Without Underlying Lung Disease (NCT00371527) | Kaiser Permanente | 2002-10-01 |
| A Study of the Effectiveness and Safety of High Dose, Short-course Levofloxacin in the Treatment of Acute Bacterial Exacerbation (Worsening) of Chronic Bronchitis. (NCT00042718) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2001-11-01 |
| Cardiopulmonary Effects of Particulate Exposure (NCT00011310) | National Institute of Environmental Health Sciences (NIEHS) | 1999-03-01 |
| Medication Adherence in COPD--A Self-Regulation Study (NCT00005717) | National Heart, Lung, and Blood Institute (NHLBI) | 1990-08-01 |
| Inflammation, Autonomic Dysfunction and Airway Disease (NCT00005298) | National Heart, Lung, and Blood Institute (NHLBI) | 1990-07-01 |
| Tucson Epidemiology Study of Chronic Obstructive Lung Diseases (NCT00005279) | National Heart, Lung, and Blood Institute (NHLBI) | 1971-06-01 |
| Honolulu Heart Program (NCT00005123) | National Heart, Lung, and Blood Institute (NHLBI) | 1965-07-01 |
| A Study of the Safety and Effectiveness of Levofloxacin Compared With Cefaclor in the Treatment of Adults With Chronic Bronchitis Experiencing Rapid Onset of Worsening of Symptoms Caused by Bacteria (NCT00257140) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1931-06-01 |